Clinical trial
Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients With Persistent Atrial Fibrillation
NCT00613496 is registered in ClinicalTrials.gov with University of Magdeburg as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of Irbesartan on Oxidative Stress and C-Reactive Protein Levels in Patients With Persistent Atrial Fibrillation
- Lead sponsor
- University of Magdeburg
- Phase
- Phase 4
- Overall status
- Unknown status
- Start date
- May 31, 2009
- Completion date
- May 31, 2010
- Enrollment
- 60 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
persistent atrial fibrillation